Douglas Guptill

Title: Douglas Guptill: A Pioneer in Evolved Interferon-Alpha Polypeptides

Introduction

Douglas Guptill, located in Mountain View, CA, is an innovative inventor known for his significant contributions to the field of biotechnology. His work primarily focuses on evolving interferon-alpha polypeptides, which hold great promise in various therapeutic applications. With one patent to his name, Guptill continues to push the boundaries of scientific discovery.

Latest Patents

Douglas Guptill's patent, titled "Evolved Interferon-Alpha Polypeptides," provides a groundbreaking approach to the development of these polypeptides. The patent covers the evolved polypeptides, their conjugates, and the nucleic acids that encode these proteins. Additionally, the invention includes various compositions comprising these elements, methods for their production, and applications of these polypeptides in the medical field.

Career Highlights

Guptill's career has been notably marked by his role at Maxygen, Inc., a company renowned for its innovative biotechnology solutions. His expertise and research have contributed to advancing the understanding and usage of interferon-alpha polypeptides, making a lasting impact on the field.

Collaborations

Throughout his career, Douglas Guptill has collaborated with other talented individuals in his field, including Madan M Paidhungat and Ian J Sas. These collaborations have helped facilitate knowledge sharing and research progression within the realm of biopharmaceuticals.

Conclusion

In conclusion, Douglas Guptill stands out as an influential inventor whose work on evolved interferon-alpha polypeptides continues to pave the way for innovative therapeutic solutions. With his patent and collaborative efforts at Maxygen, Inc., Guptill exemplifies the spirit of innovation that drives advancements in the biotechnology industry.